Falloff in Life Sciences Trickles Down to Funds

Healthcare stocks have been hard hit by RFK Jr.’s nomination to head HHS.

Pharma sector index, stock exchange.

Torsten Asmus/Getty Images

Call it the Kennedy effect.

The Nasdaq Biotechnology Index fell 12.4 percent from November 8 through December 30. So it’s not surprising that most biopharma and life sciences hedge funds posted sharp losses in December, the second straight losing month for many of these funds.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related